// App-Quantinova.ai

PB0213 : Results from B-LIEVE, a Phase 1/2 Dose-Confirmation Study of FLT180a AAV Gene Therapy in Patients with Hemophilia B

Researchers

Presenter

  • G. Young

Principal Investigators

  • P. Chowdary

  • S. Barton

  • D. Yee

  • F. Ferrante

Medical Centers

  • Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA, Los Angeles, California, United States

  • The Royal Marsden Hospital, London, United Kingdom

  • Freeline, Stevenage, England, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved